ProfileGDS4718 / 1553176_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 14% 18% 18% 16% 17% 18% 19% 17% 18% 17% 18% 14% 19% 17% 15% 17% 15% 21% 10% 20% 19% 16% 17% 20% 17% 16% 18% 22% 17% 17% 16% 16% 13% 14% 20% 19% 16% 16% 19% 20% 21% 17% 18% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0629317
GSM549102patient 115, normal, homogenized [OPG study]3.9491914
GSM549104patient 119, normal, homogenized [OPG study]4.0487418
GSM549108patient 138, normal, homogenized [OPG study]4.11618
GSM549119patient 077, normal, homogenized [OPG study]4.0034116
GSM549133patient 032, cancer, homogenized [OPG study]3.9808517
GSM549139patient 042, cancer, homogenized [OPG study]4.0379118
GSM549099patient 107, normal, homogenized [OPG study]4.1327519
GSM549109patient 139, normal, homogenized [OPG study]4.0551117
GSM549110patient 046, normal, homogenized [OPG study]4.0724218
GSM549114patient 063, normal, homogenized [OPG study]3.9898217
GSM549122patient 082, normal, homogenized [OPG study]4.0613418
GSM549134patient 033, cancer, homogenized [OPG study]3.9172314
GSM549136patient 036, cancer, homogenized [OPG study]4.0474519
GSM549140patient 044, cancer, homogenized [OPG study]3.9848417
GSM549111patient 047, normal, homogenized [OPG study]3.9253415
GSM549113patient 057, normal, homogenized [OPG study]3.9898717
GSM549132patient 031, cancer, homogenized [OPG study]3.9527615
GSM549137patient 038, cancer, homogenized [OPG study]4.1876621
GSM549142patient 047, cancer, homogenized [OPG study]3.8433910
GSM549100patient 110, normal, homogenized [OPG study]4.1456820
GSM549107patient 135, normal, homogenized [OPG study]4.0899919
GSM549115patient 068, normal, homogenized [OPG study]3.9624216
GSM549116patient 072, normal, homogenized [OPG study]4.0139217
GSM549120patient 078, normal, homogenized [OPG study]4.1428520
GSM549131patient 030, cancer, homogenized [OPG study]3.9892617
GSM549118patient 074, normal, homogenized [OPG study]4.019616
GSM549129patient 027, cancer, homogenized [OPG study]4.0761318
GSM549123patient 088, normal, homogenized [OPG study]4.2082922
GSM549124patient 006, cancer, homogenized [OPG study]4.0851217
GSM549126patient 015, cancer, homogenized [OPG study]4.0139217
GSM549128patient 025, cancer, homogenized [OPG study]3.9689416
GSM549103patient 117, normal, homogenized [OPG study]4.0271116
GSM549117patient 073, normal, homogenized [OPG study]3.885813
GSM549138patient 041, cancer, homogenized [OPG study]3.9177414
GSM549141patient 045, cancer, homogenized [OPG study]4.0889320
GSM549130patient 028, cancer, homogenized [OPG study]4.136419
GSM549101patient 111, normal, homogenized [OPG study]4.0171316
GSM549105patient 128, normal, homogenized [OPG study]4.0094516
GSM549106patient 134, normal, homogenized [OPG study]4.0546619
GSM549112patient 048, normal, homogenized [OPG study]4.133220
GSM549125patient 011, cancer, homogenized [OPG study]4.1912721
GSM549127patient 024, cancer, homogenized [OPG study]4.0233817
GSM549135patient 035, cancer, homogenized [OPG study]4.0270618